Cargando…

Complications and long-term in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors

To investigate the complications and in-stent restenosis of endovascular treatment of severe symptomatic intracranial atherosclerotic stenosis and relevant risk factors. Three hundred and fifty-four consecutive patients with intracranial atherosclerotic stenosis (70%–99%) were retrospectively enroll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lei, Du, Hong, Zhang, Dongliang, Qiao, Zongrong, Su, Xianhui, Han, Siqin, Gao, Bu-Lang, Cao, Qinying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519467/ https://www.ncbi.nlm.nih.gov/pubmed/37747021 http://dx.doi.org/10.1097/MD.0000000000034697

Ejemplares similares

Tissue Kallikrein Prevents Restenosis After Stenting of Severe Atherosclerotic Stenosis of the Middle Cerebral Artery: A Randomized Controlled Trial
por: Shi, Ruifeng, et al.
Publicado: (2016)

Endovascular treatment of multiple intracranial aneurysms
por: Wang, Ji-Wei, et al.
Publicado: (2023)

Endovascular treatment of cerebrovascular stenosis with stent for patients with ischemic cerebrovascular disease
por: Lin, Kailong, et al.
Publicado: (2020)

Clinical study of stent forming for symptomatic internal carotid artery stenosis
por: Zhang, Yiqin, et al.
Publicado: (2020)

Identifying risk factors for in-stent restenosis in symptomatic intracranial atherosclerotic stenosis: a systematic review and meta-analysis
por: Wang, Ning, et al.
Publicado: (2023)

Hemodynamic and Geometric Risk Factors for In-Stent Restenosis in Patients with Intracranial Atherosclerotic Stenosis
por: Song, Xiaowen, et al.
Publicado: (2022)

Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021)

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
por: Zhang, Kun, et al.
Publicado: (2021)

The hepatitis B core antibody positive/hepatitis B surface antigen negative pattern is associated with the increased risk of intracranial atherosclerotic stenosis
por: Shen, Lin, et al.
Publicado: (2020)

Blood biomarkers of progressive atherosclerosis and restenosis after stenting of symptomatic intracranial artery stenosis
por: Haidegger, Melanie, et al.
Publicado: (2021)

Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019)

Protective effect of the microcatheter placed at the normal vertebral artery in intracranial stent-assisted angioplasty for vertebral artery stenosis: A case report
por: Wang, Ming-Yi, et al.
Publicado: (2017)

Baseline vessel wall magnetic resonance imaging characteristics associated with in-stent restenosis for intracranial atherosclerotic stenosis
por: Tian, Bing, et al.
Publicado: (2023)

Predictors of hyperperfusion syndrome after stent implantation in symptomatic intracranial atherosclerotic stenosis
por: Yan, Long, et al.
Publicado: (2022)

Wingspan Stenting for Severe Symptomatic Intracranial Atherosclerotic Stenosis in 433 Patients Treated at a Single Medical Center
por: Li, Tian-Xiao, et al.
Publicado: (2015)

Headache improvement after intracranial endovascular procedures in Chinese patients with unruptured intracranial aneurysm: A prospective observational study
por: Zhang, Linjing, et al.
Publicado: (2017)

Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Disease
por: Short, Jody L., et al.
Publicado: (2011)

Symptomatic Atherosclerotic Disease and Decreased Risk of Cancer-Specific Mortality: A Prospective, Population-Based Study (NEDICES)
por: Benito-León, Julián, et al.
Publicado: (2015)

Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
por: Guo, Xu, et al.
Publicado: (2021)

Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients
por: Feng, Zhengzhe, et al.
Publicado: (2015)

Corrigendum: Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
por: Guo, Xu, et al.
Publicado: (2021)

Significant improvement of procedural safety in stenting for basilar stenosis: A historically controlled study
por: Wang, Kai, et al.
Publicado: (2022)

Safety and efficacy of enterprise stenting for symptomatic atherosclerotic severe posterior circulation stenosis
por: Zhou, Zhi-Long, et al.
Publicado: (2023)

Safety and effects of endovascular treatment of basilar tip aneurysms in patients with moyamoya diseases
por: Chen, Chun-Guang, et al.
Publicado: (2023)

Is the future of symptomatic intracranial atherosclerotic stenosis management promising?
por: Liu, Dacheng, et al.
Publicado: (2020)

Intervals of endovascular treatment for coincidental non-adjacent unruptured aneurysms in patients with symptomatic intracranial atherosclerotic stenosis
por: Jin, Hengwei, et al.
Publicado: (2022)

Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis
por: Ueda, Toshihiro, et al.
Publicado: (2022)

(1)H-NMR-Based Metabolomic Analysis of Cerebrospinal Fluid From Adult Bilateral Moyamoya Disease: Comparison With Unilateral Moyamoya Disease and Atherosclerotic Stenosis
por: Jeon, Jin Pyeong, et al.
Publicado: (2015)

Clinical and angiographic outcomes following endovascular treatment of very small (3 mm or smaller) intracranial aneurysm: A single-center experience
por: Liu, Yongsheng, et al.
Publicado: (2017)

Low free triiodothyronine levels predict symptomatic intracranial hemorrhage and worse short-term outcome of thrombolysis in patients with acute ischemia stroke
por: Qiu, Mingjing, et al.
Publicado: (2017)

Outcome of Endovascular Treatment in Symptomatic Intracranial Vascular Stenosis
por: Suh, Dae Chul, et al.
Publicado: (2005)

r-tPA with loading dose of clopidogrel and aspirin therapies for capsular warning syndrome attributed to middle cerebral artery atherosclerotic stenosis: A CARE-compliant case report
por: Xu, Jinghan, et al.
Publicado: (2020)

Predictors of intracranial hemorrhage after mechanical thrombectomy using a stent-retriever for anterior circulation ischemic stroke: A retrospective study
por: Lee, In-Hyoung, et al.
Publicado: (2023)

Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)

Safety of Low-Dose Aspirin in Endovascular Treatment for Intracranial Atherosclerotic Stenosis
por: Ma, Ning, et al.
Publicado: (2014)

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects
por: Luo, Jichang, et al.
Publicado: (2018)

Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
por: Park, Jong-Ho, et al.
Publicado: (2017)

A Need for Tailored Approach for Patients with Symptomatic Intracranial Atherosclerotic Stenosis
por: Kate, Mahesh P., et al.
Publicado: (2020)

Radiomics Nomogram for Predicting Stroke Recurrence in Symptomatic Intracranial Atherosclerotic Stenosis
por: Tang, Min, et al.
Publicado: (2022)

Outcomes of Endovascular Stenting in Symptomatic Vertebral Artery Ostial Stenosis
por: El Koussa, Roy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ngf7aas8djidl3aa79ei7sab9t